Atea Pharmaceuticals, Inc. (AVIR)
3.945
-0.04
(-1.13%)
USD |
NASDAQ |
Nov 19, 16:00
3.945
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals EPS Diluted (Quarterly) : -0.4009 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.4009 |
| June 30, 2026 | -0.4114 |
| March 31, 2026 | -0.5738 |
| December 31, 2025 | -0.5743 |
| September 30, 2025 | -0.5319 |
| June 30, 2025 | -0.4437 |
| March 31, 2025 | -0.4024 |
| December 31, 2024 | -0.3971 |
| September 30, 2024 | -0.369 |
| June 30, 2024 | -0.481 |
| March 31, 2024 | -0.7528 |
| December 31, 2023 | -0.4694 |
| September 30, 2023 | -0.3974 |
| June 30, 2023 | -0.3379 |
| March 31, 2023 | -0.4256 |
| December 31, 2022 | -0.4134 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.0969 |
| June 30, 2022 | -0.3764 |
| March 31, 2022 | -0.5059 |
| December 31, 2021 | 1.345 |
| September 30, 2021 | -0.3404 |
| June 30, 2021 | 0.0175 |
| March 31, 2021 | 0.3447 |
| December 31, 2020 | 0.2506 |
| September 30, 2020 | -0.2133 |
| June 30, 2020 | -0.121 |
| March 31, 2020 | -0.0483 |
| December 31, 2019 | -0.0563 |
| September 30, 2019 | -0.044 |
| June 30, 2019 | -0.043 |
| March 31, 2019 | -0.0265 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.2213 |
| CorMedix, Inc. | -0.1877 |
| Eloxx Pharmaceuticals, Inc. | -0.486 |
| Breakthrough Chemistry, Inc. | -0.1113 |
| BioStem Technologies, Inc. | -0.6368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.16M |
| Total Expenses (Quarterly) | 32.16M |
| Enterprise Value | 129.39M |
| Earnings Yield | -49.69% |
| Normalized Earnings Yield | -49.69 |